what to expect with tirzepatide Side Effects: Safety and Risks Starting a GLP-1 medication is

The rise in systolic blood pressure results from a 1 mediated increase in heart rate and ventricular contractility The rise in diastolic pressure results from stimulation of 1 and 2 receptor mediated vasoconstriction in many vascular beds Epinephrine also stimulates 2 receptors present in skeletal muscle blood vessels, resulting in their dilation at low doses, at which 2 receptor stimulation predominates over receptor stimulation, total peripheral resistance and diastolic pressure may fall FDA Indications: Figure 1

Key differences in bioavailability: Prescription injections: High bioavailability due to direct delivery into the bloodstream OTC oral supplements: Variable bioavailability due to gastrointestinal absorption factors Understanding the differences between prescription B12 injections and OTC supplements helps healthcare providers tailor treatments

Zhao, L

D.ThomasW.KenslerT

Injecting subcutaneously allows for a slower, more sustained release of the peptides into the bloodstream

Define criteria for safely resuming GLP-1 therapy after surgery Only restart GLP-1 when the patient is hemodynamically stable, tolerating oral intake and has no acute infectious or bleeding issues